Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents
Which is advantageous for identification: antigen, CDR, cross-reactivity, or hybridoma?
★What constitutes a strong patent specification and claims when acquiring rights for antibody drugs? ★Along with essential practical knowledge, we will teach you claim techniques that your company may not know, incorporating exercises! 【Instructor】Akihiko Okuno, Representative Employee, SK Patent Firm, Patent Attorney 【Venue】Tekuno Kawasaki, 5th Floor, Room 5 Training 【Kanagawa, Musashi-Mizonokuchi Station】 【Date and Time】November 29, 2010 (Monday) 13:00–16:00 【Lecture ends at 16:00. 16:00-16:30: Free Time Q&A】
![002426[1].jpg](https://image.mono.ipros.com/public/product/image/ac0/2000000843/IPROS328403787895015065.jpg?w=280&h=280)
Inquire About This Product
basic information
【Course Overview】 When acquiring rights to antibody drugs, what is the best way to secure those rights? This course will explain how to effectively secure rights while concealing know-how, taking into account not only patent practices but also case law and decisions from various countries, as well as recent technological innovations.
Price information
New members who apply for the first time by November 15 will receive an early bird discount price of 39,900 yen.
Price range
P2
Delivery Time
P2
※Expected delivery date of the course ticket.
Applications/Examples of results
0. Intellectual Property Strategy for Biotech and Pharmaceutical Companies 0-1. Analysis of the Current Status of the Antibody Drug Market 1. How to Write Strong Patent Specifications and Claims for Antibody Drugs 1-1. What Constitutes a Strong Patent Specification and Claim? - Smooth acquisition of rights - Not invalidated in opposition proceedings - Able to deter rival companies after publication - Able to eliminate rival companies in litigation - Does not reveal the company’s research and development strategy - Applicable in any country 1-2. How to Write Specifications that Meet Enablement Requirements 1-3. How to Write Claims that Meet Novelty and Inventive Step Requirements 1-4. The Concept of Universal Drafting 2. Exercises on How to Write Claims 2-1. Questions Based on Hypothetical Experimental Data - Cases with distinctive features in antibody composition - Cases with distinctive biochemical actions of antibodies in vitro - Cases with distinctive features in diseases, conditions, or patients affected by antibodies 2-2. Review of Claims - Novelty and Inventive Step - Enablement Requirements - Technical Scope - Overall Review and Awards for Excellence 【Q&A】
Company information
Our company has developed its business from "seminar planning" to various forms such as "lecturer dispatch," "publishing planning," "technical consultant dispatch," "trend research," "business matching," and "business development consulting," in order to support clients in a wide range of fields including chemistry, electronics, automotive, energy, medical devices, food, and building materials. By doing so, we have advanced our company and opened up new markets. AndTech promises to continue listening to our clients' voices, entering the business areas and markets they desire, and to remain a company that is loved by our clients, as we share their challenges, think together, and forge new paths.
![[Research Material] Global Market for B Cell Maturation Antigen (BCMA) Targeted Therapy](https://image.mono.ipros.com/public/product/image/bc1/2001481377/IPROS33427504888589454849.jpeg?w=280&h=280)
![[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country](https://image.mono.ipros.com/public/product/image/3d2/2001181608/IPROS32315136463393769928.png?w=280&h=280)
![[Service Example] Major Pharmaceutical Company J](https://image.mono.ipros.com/public/product/image/10b/2001524340/IPROS10464393397006182558.png?w=280&h=280)
